The management of febrile neutropenia in the posaconazole era: a new challenge?
作者信息
Pagano Livio, Caira Morena, Cuenca-Estrella Manuel
出版信息
Haematologica. 2012 Jul;97(7):963-5. doi: 10.3324/haematol.2012.062166.
Abstract
摘要
相似文献
1
The management of febrile neutropenia in the posaconazole era: a new challenge?泊沙康唑时代发热性中性粒细胞减少症的管理：一项新挑战？
Haematologica. 2012 Jul;97(7):963-5. doi: 10.3324/haematol.2012.062166.
2
Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation.泊沙康唑成功治疗中性粒细胞减少症期间及随后异基因造血干细胞移植过程中的播散性镰刀菌病。
Transpl Infect Dis. 2007 Jun;9(2):156-60. doi: 10.1111/j.1399-3062.2006.00189.x.
3
[Prophylaxis use of posaconazole (P) in an hemato-oncology unit: a retrospective study].[泊沙康唑（P）在血液肿瘤病房的预防性应用：一项回顾性研究]
Pathol Biol (Paris). 2010 Apr;58(2):123-6. doi: 10.1016/j.patbio.2009.07.016. Epub 2009 Oct 27.
4
Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.在新型广谱抗真菌药物和诊断辅助手段时代，癌症和中性粒细胞减少患者以及干细胞移植受者侵袭性真菌感染的预防和早期治疗
Clin Infect Dis. 2007 Feb 1;44(3):402-9. doi: 10.1086/510677. Epub 2007 Jan 2.
5
Second- versus first-generation azoles for antifungal prophylaxis in hematology patients: a systematic review and meta-analysis.二代和一代唑类抗真菌药物用于血液科患者的预防真菌感染：系统评价和荟萃分析。
Ann Hematol. 2013 Jun;92(6):831-9. doi: 10.1007/s00277-013-1693-5. Epub 2013 Feb 28.
6
Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis.泊沙康唑与氟康唑或伊曲康唑预防急性髓系白血病或骨髓增生异常综合征患者接受强化细胞毒化疗后侵袭性真菌感染的成本效果分析。
Support Care Cancer. 2011 Nov;19(11):1807-13. doi: 10.1007/s00520-010-1022-7. Epub 2010 Oct 23.
7
Is Posaconazole Really Effective in Adolescent patients as a Prophylactic Agent: Experience of a Tertiary Care Center.泊沙康唑在青少年患者中作为预防药物是否真的有效：一家三级医疗中心的经验。
J Pediatr Hematol Oncol. 2021 Jul 1;43(5):e613-e618. doi: 10.1097/MPH.0000000000002080.
8
Persistent fever in patients with neutropenia.中性粒细胞减少患者的持续发热。
N Engl J Med. 2002 Jan 24;346(4):222-4. doi: 10.1056/NEJM200201243460402.
9
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.伏立康唑作为造血干细胞移植或急性髓系白血病化疗后中性粒细胞减少患者的主要抗真菌预防用药。
Eur J Haematol. 2010 Mar;84(3):271-3. doi: 10.1111/j.1600-0609.2009.01367.x. Epub 2009 Oct 29.
10
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.泊沙康唑与氟康唑或伊曲康唑对中性粒细胞减少患者的预防作用比较
N Engl J Med. 2007 Jan 25;356(4):348-59. doi: 10.1056/NEJMoa061094.
引用本文的文献
1
Antifungal Prophylaxis and Treatment of Breakthrough Invasive Fungal Diseases in High-Risk Hematology Patients: A Prospective Observational Multicenter Study.高危血液病患者侵袭性真菌病突破性感染的抗真菌预防与治疗：一项前瞻性观察性多中心研究
Indian J Hematol Blood Transfus. 2025 Jan;41(1):75-88. doi: 10.1007/s12288-024-01790-2. Epub 2024 May 20.
2
Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation.低剂量氟康唑作为异基因造血干细胞移植患者一种有用且安全的预防选择。
Cancer Med. 2024 Feb;13(3):e6815. doi: 10.1002/cam4.6815. Epub 2024 Jan 11.
3
Strategies for the management of invasive fungal infections due to filamentous fungi in high-risk hemato-oncological patients.高危血液肿瘤患者丝状真菌所致侵袭性真菌感染的管理策略
Rev Esp Quimioter. 2019 Feb;32(1):31-39. Epub 2018 Dec 13.
4
The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study.泊沙康唑用于急性髓系白血病患者抗真菌预防的疗效：一项单中心研究
Turk J Haematol. 2018 Nov 13;35(4):277-282. doi: 10.4274/tjh.2017.0430. Epub 2018 Jul 26.
5
Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).血液系统恶性肿瘤侵袭性真菌病的风险分类与预防建议：证据与专家意见的批判性综述（TEO-4）
Turk J Haematol. 2015 Jun;32(2):100-17. doi: 10.4274/tjh.2014.0277.
6
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).侵袭性真菌病的化疗前危险因素：对1192例新诊断急性髓系白血病患者的前瞻性分析（SEIFEM 2010——一项多中心研究）
Haematologica. 2015 Feb;100(2):284-92. doi: 10.3324/haematol.2014.113399.
本文引用的文献
1
The role of antifungal treatment in hematology.抗真菌治疗在血液学中的作用。
Haematologica. 2012 Mar;97(3):325-7. doi: 10.3324/haematol.2012.061952.
2
Early implementation of antifungal therapy in the management of febrile neutropenia is associated with favourable outcome during induction chemotherapy for acute leukaemias.早期实施抗真菌治疗在急性白血病诱导化疗期间发热性中性粒细胞减少症的管理中与良好的结果相关。
Intern Med J. 2012 Feb;42(2):131-6. doi: 10.1111/j.1445-5994.2011.02638.x.
3
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.12 年期间接受细胞毒化疗的急性髓系白血病/骨髓增生异常综合征患者中，预防性伏立康唑/泊沙康唑与氟康唑/伊曲康唑的临床疗效比较。
Haematologica. 2012 Mar;97(3):459-63. doi: 10.3324/haematol.2011.051995. Epub 2011 Nov 4.
4
Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis.抗真菌治疗会影响侵袭性曲霉菌病的实验室诊断。
J Clin Pathol. 2012 Jan;65(1):83-6. doi: 10.1136/jcp.2011.090464. Epub 2011 Nov 2.
5
Concentration of antifungal agents within host cell membranes: a new paradigm governing the efficacy of prophylaxis.宿主细胞膜内抗真菌药物浓度：预防有效性的新范例。
Antimicrob Agents Chemother. 2011 Dec;55(12):5732-9. doi: 10.1128/AAC.00637-11. Epub 2011 Sep 19.
6
ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients.欧洲癌症研究与治疗组织（ECIL）关于白血病患者和造血干细胞移植受者侵袭性真菌病诊断中生物标志物使用的建议。
Bone Marrow Transplant. 2012 Jun;47(6):846-54. doi: 10.1038/bmt.2011.178. Epub 2011 Sep 19.
7
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project.经验性治疗与抢先性治疗在真菌感染管理中的应用和疗效：HEMA 电子图表项目。
Haematologica. 2011 Sep;96(9):1366-70. doi: 10.3324/haematol.2011.042598. Epub 2011 May 12.
8
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.以半乳甘露聚糖为指导的抢先与经验性抗真菌治疗在持续发热中性粒细胞减少患者中的前瞻性随机研究。
Int J Infect Dis. 2011 May;15(5):e350-6. doi: 10.1016/j.ijid.2011.01.011. Epub 2011 Mar 11.
9
Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole.预防性使用泊沙康唑治疗的急性髓细胞白血病患者侵袭性曲霉菌病的危险因素。
Med Mycol. 2011 Oct;49(7):681-7. doi: 10.3109/13693786.2011.557668. Epub 2011 Feb 11.
10
Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients.免疫功能低下患者中与霉菌相关疾病的风险评估和预后因素。
J Antimicrob Chemother. 2011 Jan;66 Suppl 1:i5-14. doi: 10.1093/jac/dkq437.
Zotero 插件